CA
NZ
UK
AU
IND
US
Dickinson (NYSE:BDX). The transaction that defined BD's last two years is complete. The company spun off its Biosciences and Diagnostic Solutions businesses and merged them with a WatersSubsidiaryin a tax-efficientReverse Morris Trustvalued at roughly $17.5 billion when announced. BD shareholders of record on 5 …
Abbott (NYSE:ABT) reported second-quarter 2026 sales of $12.593 billion on 16 July, up 13.0% as reported and 4.8% on an organic basis, with adjusted diluted earnings of $1.31 per share against a consensus of $1.28.Revenuealso came in ahead of the roughly $12.50 billion analysts …
AbbVie (NYSE:ABBV) reported second-quarter results before the open at last closing and did nearly everything asked of it. Net revenue rose 10.2% on a reported basis to $16.990 billion, ahead of the roughly $16.77 billion analysts had modeled. Skyrizi and Rinvoq, the pair engineered …
Technologies (NYSE:A). For most of fiscal 2024 and 2025, owning analytical-instrument makers was an exercise in waiting out a hangover. Laboratory customers who had over-ordered during thePandemicsimply stopped buying. Revenue fell 4.7% in fiscal 2024 to $6.51 billion after a flat fiscal 2023, then …
Technology (Nasdaq:ALGN). Second-quarter revenue of $1,056.2 million, reported on 29 July, was the highest in the company's history, up 4.3% year over year. Clear Aligner shipments of 691,785 cases were also a record, up 7.4%. Non-GAAPEarningsof $2.64 a share beat the $2.60 consensus tracked …
SCYNEXIS (Nasdaq:SCYX) closed on Friday 31 July 2026 up 29.76% at $4.84 on the TradingView screener, on roughly 3.18 million shares. A second data provider records the close at $4.81 and the gain at 28.95%; the difference is a feed variance rather than a …
On the evening of Thursday 30 July 2026, the Food and Drug Administration's Cellular, Tissue and Gene Therapies Advisory Committee voted 10 to 3 that the efficacy results from Replimune's (Nasdaq:REPL) IGNYTE trial are, in the committee's words, evaluable and clinically meaningful. The following …
Integer Holdings (NYSE:ITGR) closed at $121.21 on Friday 31 July 2026, up 20.18% from $100.86, on 2.6 million shares. Trading was briefly halted forVolatility. The session range ran from $99.52 to $123.50.
Modular Medical (Nasdaq:MODD) closed at $2.39 on Friday 31 July 2026, up 15.46%. In the same session the shares touched $1.96, a new low. That combination (a double-digit percentage gain and a fresh floor on the same tape) describes a security being sold into …
CNS Pharmaceuticals (Nasdaq:CNSP) closed at $5.82 on Friday 31 July 2026, up 19.94% from $4.85.Volumewas 11,738 shares. Against a three-month average near 9,462 shares, relative volume was roughly 1.2 times. There was effectively no volume surge at all. The entire session represented about $68,000 …
Please wait processing your request...